-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
Basic Information
-- Beijing Northland Biotechnology Co., Ltd. --
|
Full company name
|
Beijing Northland Biotechnology Co., Ltd. (stock code: 920047)
|
|
English name
|
Beijing Northland Biotech Co., Ltd.
|
|
Legal representative
|
Xu Songshan
|
|
Company Secretary
|
Highly pure
|
|
Registered capital
|
274.271974 million yuan
|
|
Date of Establishment
|
2004/6/3
|
|
Listing date
|
2021/11/15 (Beijing Stock Exchange)
|
|
Postal code
|
100085
|
|
Company phone
|
|
|
Company Fax
|
|
|
Company website
|
|
|
Sponsoring Broker
|
China-Thailand Securities Co., Ltd.
|
|
Contact email
|
Corporate Governance
— Introduction to the Company’s Major Shareholders, Directors, and Supervisors —
Corporate Governance
Listing Company Announcement Query Address for the Beijing Stock Exchange:
Shareholder Mailbox
— Thank you for your attention to NORTHLAND! If you have any questions, please leave a message, and we’ll get back to you as soon as possible!
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005